Calderon, M A; Demoly, P; Casale, T; Akdis, C A; Bachert, C; Bewick, M; Bilò, B M; Bohle, B; Bonini, S; Bush, A; Caimmi, D P; Canonica, G W; Cardona, V; Chiriac, A M; Cox, L; Custovic, A; De Blay, F; Devillier, P; Didier, A; Di Lorenzo, G; Du Toit, G; Durham, S R; Eng, P; Fiocchi, A; Fox, A T; van Wijk, R Gerth; Gomez, R M; Haathela, T; Halken, S; Hellings, P W; et al (2016). Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clinical and Translational Allergy, 6:41.
Bousquet, J; Schünemann, H J; Bousquet, P J; Bachert, C; Canonica, G W; Casale, T B; Demoly, P; Durham, S; Carlsen, K H; Malling, H J; Passalacqua, G; Simons, F E R; Anto, J; Baena-Cagnani, C E; Bergmann, K C; Bieber, T; Briggs, A H; Brozek, J; Calderon, M A; Dahl, R; Devillier, P; Gerth van Wijk, R; Howarth, P; Larenas, D; Papadopoulos, N G; Schmid-Grendelmeier, P; Zuberbier, T (2011). How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy, 66(6):765-774.